Sowell Financial Services LLC Abb Vie Inc. Transaction History

Sowell Financial Services LLC

$2.1 Billion
Q3 2024

A detailed history of Sowell Financial Services LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sowell Financial Services LLC holds 57,826 shares of ABBV stock, worth $10.4 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

57,826

Previous 61,785 6.41%

Holding current value

$10.4 Million

Previous $10.6 Million 7.76%

% of portfolio

0.54%

Previous 0.52%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	SELL	$163.84 - $199.33 $648,642 - $789,147	-3,959 Reduced 6.41%	57,826 $11.4 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $386,975 - $451,900	2,500 Added 4.22%	61,785 $10.6 Million
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $79,590 - $90,685	-498 Reduced 0.83%	59,285 $10.8 Million
Q4 2023 Jan 24, 2024	SELL	$137.6 - $154.97 $207,776 - $234,004	-1,510 Reduced 2.46%	59,783 $9.26 Million
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $333,707 - $386,315	2,498 Added 4.25%	61,293 $9.14 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $2.12 Million - $2.64 Million	16,027 Added 37.47%	58,795 $7.92 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $2.23 Million - $2.57 Million	-15,438 Reduced 26.52%	42,768 $6.82 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $2.08 Million - $2.5 Million	15,067 Added 34.93%	58,206 $9.41 Million
Q3 2022 Nov 15, 2022	SELL	$134.21 - $153.93 $206,683 - $237,052	-1,540 Reduced 3.45%	43,139 $5.79 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $3.65 Million - $4.64 Million	26,537 Added 146.27%	44,679 $6.84 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $2.93 Million - $3.63 Million	-22,167 Reduced 54.99%	18,142 $2.92 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $1.24 Million - $1.57 Million	-11,540 Reduced 22.26%	40,309 $5.46 Million
Q3 2021 Nov 04, 2021	SELL	$106.4 - $120.78 $3.82 Million - $4.34 Million	-35,907 Reduced 40.92%	51,849 $5.59 Million
Q2 2021 Aug 05, 2021	SELL	$105.21 - $117.21 $1.27 Million - $1.41 Million	-12,031 Reduced 12.06%	87,756 $9.89 Million
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $1.13 Million - $1.24 Million	11,029 Added 12.43%	99,787 $11.6 Million
Q4 2020 Jan 13, 2021	BUY	$80.49 - $108.67 $177,641 - $239,834	2,207 Added 2.55%	88,758 $9.51 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $680,664 - $798,876	7,923 Added 10.08%	86,551 $7.58 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $1.59 Million - $2.13 Million	21,662 Added 38.03%	78,628 $7.72 Million
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $275,415 - $417,563	4,270 Added 8.1%	56,966 $4.34 Million
Q4 2019 Feb 07, 2020	SELL	$72.13 - $90.25 $57,487 - $71,929	-797 Reduced 1.49%	52,696 $4.67 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $491,558 - $590,994	7,805 Added 17.08%	53,493 $4.05 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $149,034 - $175,406	1,932 Added 4.42%	45,688 $0
Q4 2018 Mar 05, 2019	BUY	$77.85 - $96.01 $269,672 - $332,578	3,464 Added 8.6%	43,756 $4.03 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $127,496 - $141,736	1,434 Added 3.69%	40,292 $3.81 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $140,326 - $166,037	1,563 Added 4.19%	38,858 $3.76 Million
Q1 2018 May 10, 2018	SELL	$92.01 - $123.21 $894,981 - $1.2 Million	-9,727 Reduced 20.69%	37,295 $3.74 Million
Q4 2017 Jan 29, 2018	SELL	$89.56 - $98.21 $302,085 - $331,262	-3,373 Reduced 6.69%	47,022 $4.88 Million
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $3.52 Million - $4.5 Million	50,395	50,395 $4.66 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.

Account

Sowell Financial Services LLC Abb Vie Inc. Transaction History